SEARCH

SEARCH BY CITATION

References

  • Aksan, I., and Goding, C.R. (1998). Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol. Cell. Biol. 18, 69306938.
  • Allen, J.D., Lints, T., Jenkins, N.A., Copeland, N.G., Strasser, A., Harvey, R.P., and Adams, J.M. (1991). Novel murine homeo box gene on chromosome 1 expressed in specific hematopoietic lineages and during embryogenesis. Genes Dev. 5, 509520.
  • Amoh, Y., Li, L., Katsuoka, K., Penman, S., and Hoffman, R.M. (2005). Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc. Natl. Acad. Sci. U.S.A. 102, 55305534.
  • Amstutz, R., Wachtel, M., Troxler, H., Kleinert, P., Ebauer, M., Haneke, T., Oehler-Janne, C., Fabbro, D., Niggli, F.K., and Schafer, B.W. (2008). Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities. Cancer Res. 68, 37673776.
  • Anderson, M.J., Shelton, G.D., Cavenee, W.K., and Arden, K.C. (2001). Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl. Acad. Sci. U.S.A. 98, 15891594.
  • Asher, J.H. Jr, and Friedman, T.B. (1990). Mouse and hamster mutants as models for Waardenburg syndromes in humans. J. Med. Genet. 27, 618626.
  • Auerbach, R. (1954). Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127, 305329.
  • Bajard, L., Relaix, F., Lagha, M., Rocancourt, D., Daubas, P., and Buckingham, M.E. (2006). A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev. 20, 24502464.
  • Baldwin, C.T., Hoth, C.F., Amos, J.A., Da-Silva, E.O., and Milunsky, A. (1992). An exonic mutation in the HuP2 paired domain gene causes Waardenburg’s syndrome. Nature 355, 637638.
  • Barber, T.D., Barber, M.C., Cloutier, T.E., and Friedman, T.B. (1999). PAX3 gene structure, alternative splicing and evolution. Gene 237, 311319.
  • Barr, F.G. (1997). Molecular genetics and pathogenesis of rhabdomyosarcoma. J. Pediatr. Hematol. Oncol. 19, 483491.
  • Barr, F.G. (2001). Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20, 57365746.
  • Barr, F.G., Galili, N., Holick, J., Biegel, J.A., Rovera, G., and Emanuel, B.S. (1993). Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3, 113117.
  • Barr, F.G., Nauta, L.E., and Hollows, J.C. (1998). Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma. Cancer Genet. Cytogenet. 102, 3239.
  • Barr, F.G., Fitzgerald, J.C., Ginsberg, J.P., Vanella, M.L., Davis, R.J., and Bennicelli, J.L. (1999). Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59, 54435448.
  • Bendall, A.J., Ding, J., Hu, G., Shen, M.M., and Abate-Shen, C. (1999). Msx1 antagonizes the mitogenic activity of Pax3 in migrating limb muscle precursors. Development 126, 49654976.
  • Bennicelli, J.L., Fredericks, W.J., Wilson, R.B., Rauscher, F.J. III, and Barr, F.G. (1995). Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11, 119130.
  • Bernasconi, M., Remppis, A., Fredericks, W.J., Rauscher, F.J. III, and Schafer, B.W. (1996). Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc. Natl. Acad. Sci. U.S.A. 93, 1316413169.
  • Bertolotto, C., Busca, R., Abbe, P., Bille, K., Aberdam, E., Ortonne, J.P., and Ballotti, R. (1998). Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol. Cell. Biol. 18, 694702.
  • Bober, E., Franz, T., Arnold, H.H., Gruss, P., and Tremblay, P. (1994). Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 120, 603612.
  • Bondurand, N., Pingault, V., Goerich, D.E., Lemort, N., Sock, E., Le Caignec, C., Wegner, M., and Goossens, M. (2000). Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum. Mol. Genet. 9, 19071917.
  • Borycki, A.G., Li, J., Jin, F., Emerson, C.P., and Epstein, J.A. (1999). Pax3 functions in cell survival and in pax7 regulation. Development 126, 16651674.
  • Boutet, S.C., Disatnik, M.H., Chan, L.S., Iori, K., and Rando, T.A. (2007). Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell 130, 349362.
  • Brunelli, S., Relaix, F., Baesso, S., Buckingham, M., and Cossu, G. (2007). Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity. Dev. Biol. 304, 604614.
  • Candille, S.I., Van Raamsdonk, C.D., Chen, C., Kuijper, S., Chen-Tsai, Y., Russ, A., Meijlink, F., and Barsh, G.S. (2004). Dorsoventral patterning of the mouse coat by Tbx15. PLoS Biol. 2, E3.
  • Cao, Y., and Wang, C. (2000). The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain. J. Biol. Chem. 275, 98549862.
  • Carreira, S., Dexter, T.J., Yavuzer, U., Easty, D.J., and Goding, C.R. (1998). Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol. Cell. Biol. 18, 50995108.
  • Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 34263439.
  • Chalepakis, G., and Gruss, P. (1995). Identification of DNA recognition sequences for the Pax3 paired domain. Gene 162, 267270.
  • Chalepakis, G., Goulding, M., Read, A., Strachan, T., and Gruss, P. (1994a). Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc. Natl. Acad. Sci. U.S.A. 91, 36853689.
  • Chalepakis, G., Jones, F.S., Edelman, G.M., and Gruss, P. (1994b). Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. U.S.A. 91, 1274512749.
  • Chalepakis, G., Wijnholds, J., and Gruss, P. (1994c). Pax-3-DNA interaction: flexibility in the DNA binding and induction of DNA conformational changes by paired domains. Nucleic Acids Res. 22, 31313137.
  • Chow, L.M., and Baker, S.J. (2006). PTEN function in normal and neoplastic growth. Cancer Lett. 241, 184196.
  • Conway, S.J., Henderson, D.J., and Copp, A.J. (1997a). Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. Development 124, 505514.
  • Conway, S.J., Henderson, D.J., Kirby, M.L., Anderson, R.H., and Copp, A.J. (1997b). Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc. Res. 36, 163173.
  • Conway, S.J., Bundy, J., Chen, J., Dickman, E., Rogers, R., and Will, B.M. (2000). Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H))/Pax3 mouse mutant. Cardiovasc. Res. 47, 314328.
  • Cook, A.L., Smith, A.G., Smit, D.J., Leonard, J.H., and Sturm, R.A. (2005). Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp. Cell Res. 308, 222235.
  • Corry, G.N., and Underhill, D.A. (2005). Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations. Pigment Cell Res. 18, 427438.
  • Davis, R.J., Bennicelli, J.L., Macina, R.A., Nycum, L.M., Biegel, J.A., and Barr, F.G. (1995). Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma. Hum. Mol. Genet. 4, 23552362.
  • De Groot, J.W., Links, T.P., Plukker, J.T., Lips, C.J., and Hofstra, R.M. (2006). RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr. Rev. 27, 535560.
  • Delmas, V., Beermann, F., Martinozzi, S. et al. (2007). Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 21, 29232935.
  • Dickie, M.M. (1964). New Splotch Alleles in the Mouse. J. Hered., 55, 97101.
  • Dorsky, R.I., Moon, R.T., and Raible, D.W. (1998). Control of neural crest cell fate by the Wnt signalling pathway. Nature 396, 370373.
  • Ebauer, M., Wachtel, M., Niggli, F.K., and Schafer, B.W. (2007). Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR. Oncogene 26, 72677281.
  • Eberhard, D., and Busslinger, M. (1999). The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. Cancer Res. 59, 1716s1724s.
  • Eisen, T., Easty, D.J., Bennett, D.C., and Goding, C.R. (1995). The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 11, 21572164.
  • Epstein, D.J., Malo, D., Vekemans, M., and Gros, P. (1991a). Molecular characterization of a deletion encompassing the splotch mutation on mouse chromosome 1. Genomics 10, 8993.
  • Epstein, D.J., Vekemans, M., and Gros, P. (1991b). Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767774.
  • Epstein, D.J., Vogan, K.J., Trasler, D.G., and Gros, P. (1993). A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc. Natl. Acad. Sci. U.S.A. 90, 532536.
  • Epstein, J.A., Shapiro, D.N., Cheng, J., Lam, P.Y., and Maas, R.L. (1996). Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. U.S.A. 93, 42134218.
  • Farin, H.F., Mansouri, A., Petry, M., and Kispert, A. (2008). T-box protein TBX18 interacts with the paired-box protein Pax3 in the development of the paraxial mesoderm. J. Biol. Chem. 283, 2537225380.
  • Farrer, L.A., Grundfast, K.M., Amos, J. et al. (1992). Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am. J. Hum. Genet. 50, 902913.
  • Fenby, B.T., Fotaki, V., and Mason, J.O. (2008). Pax3 regulates Wnt1 expression via a conserved binding site in the 5′ proximal promoter. Biochim. Biophys. Acta 1779, 115121.
  • Foy, C., Newton, V., Wellesley, D., Harris, R., and Read, A.P. (1990). Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the Splotch mouse. Am. J. Hum. Genet. 46, 10171023.
  • Franz, T. (1989). Persistent truncus arteriosus in the Splotch mutant mouse. Anat. Embryol. 180, 457464.
  • Franz, T. (1990). Defective ensheathment of motoric nerves in the Splotch mutant mouse. Acta Anat (Basel) 138, 246253.
  • Franz, T. (1993). The Splotch (Sp1H) and Splotch-delayed (Spd) alleles: differential phenotypic effects on neural crest and limb musculature. Anat. Embryol. 187, 371377.
  • Franz, T., Kothary, R., Surani, M.A., Halata, Z., and Grim, M. (1993). The Splotch mutation interferes with muscle development in the limbs. Anat. Embryol. 187, 153160.
  • Fredericks, W.J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F.G., and Rauscher, F.J. III (1995). The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 15221535.
  • Fujii, H., and Hamada, H. (1993). A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron 11, 11971206.
  • Gad, A., Laurino, M., Maravilla, K.R., Matsushita, M., and Raskind, W.H. (2008). Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome? Am. J. Med. Genet. A 146A, 18801885.
  • Galibert, M.D., Yavuzer, U., Dexter, T.J., and Goding, C.R. (1999). Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J. Biol. Chem. 274, 2689426900.
  • Galili, N., Davis, R.J., Fredericks, W.J., Mukhopadhyay, S., Rauscher, F.J. III, Emanuel, B.S., Rovera, G., and Barr, F.G. (1993). Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230235.
  • Gallego Melcon, S., and Sanchez De Toledo Codina, J. (2007). Molecular biology of rhabdomyosarcoma. Clin. Transl. Oncol. 9, 415419.
  • Ginsberg, J.P., Davis, R.J., Bennicelli, J.L., Nauta, L.E., and Barr, F.G. (1998). Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Cancer Res. 58, 35423546.
  • Goodall, J., Wellbrock, C., Dexter, T.J., Roberts, K., Marais, R., and Goding, C.R. (2004). The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol. Cell. Biol. 24, 29232931.
  • Goodall, J., Martinozzi, S., Dexter, T.J., Champeval, D., Carreira, S., Larue, L., and Goding, C.R. (2008). Brn-2 expression controls melanoma proliferation and is directly regulated by β-catenin. Mol. Cell. Biol. 24, 29152922.
  • Goulding, M.D., Chalepakis, G., Deutsch, U., Erselius, J.R., and Gruss, P. (1991). Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10, 11351147.
  • Goulding, M.D., Lumsden, A., and Gruss, P. (1993). Signals from the notochord and floor plate regulate the region-specific expression of two Pax genes in the developing spinal cord. Development 117, 10011016.
  • Goulding, M., Lumsden, A., and Paquette, A.J. (1994). Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120, 957971.
  • Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biology and new targeted therapy. Nature 445, 851857.
  • Hageman, M.J., and Delleman, J.W. (1977). Heterogeneity in Waardenburg syndrome. Am. J. Hum. Genet. 29, 468485.
  • He, S.J., Stevens, G., Braithwaite, A.W., and Eccles, M.R. (2005). Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity. Mol. Cancer Ther. 4, 9961003.
  • Henderson, D.J., Ybot-Gonzalez, P., and Copp, A.J. (1997). Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch). Mech. Dev. 69, 3951.
  • Hollenbach, A.D., Sublett, J.E., Mcpherson, C.J., and Grosveld, G. (1999). The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18, 37023711.
  • Hollenbach, A.D., Mcpherson, C.J., Lagutina, I., and Grosveld, G. (2002). The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3. Biochim. Biophys. Acta 1574, 321328.
  • Hornyak, T., Hayes, D., Chiu, L.-Y., and Ziff, E. (2001). Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101, 4759.
  • Hoth, C.F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S.K., and Baldwin, C.T. (1993). Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455462.
  • Hsieh, M.J., Yao, Y.L., Lai, I.L., and Yang, W.M. (2006). Transcriptional repression activity of PAX3 is modulated by competition between corepressor KAP1 and heterochromatin protein 1. Biochem. Biophys. Res. Commun. 349, 573581.
  • Ikeya, M., Lee, S.M., Johnson, J.E., Mcmahon, A.P., and Takada, S. (1997). Wnt signalling required for expansion of neural crest and CNS progenitors. Nature 389, 966970.
  • Ishikiriyama, S., Tonoki, H., Shibuya, Y., Chin, S., Harada, N., Abe, K., and Niikawa, N. (1989). Waardenburg syndrome type I in a child with de novo inversion (2)(q35q37.3). Am. J. Med. Genet. 33, 505507.
  • Jiang, X., Rowitch, D.H., Soriano, P., Mcmahon, A.P., and Sucov, H.M. (2000). Fate of the mammalian cardiac neural crest. Development 127, 16071616.
  • Jiao, Z., Mollaaghababa, R., Pavan, W.J., Antonellis, A., Green, E.D., and Hornyak, T.J. (2004). Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res. 17, 352362.
  • Jun, S., and Desplan, C. (1996). Cooperative interactions between paired domain and homeodomain. Development 122, 26392650.
  • Jun, S., Wallen, R.V., Goriely, A., Kalionis, B., and Desplan, C. (1998). Lune/eye gone, a Pax-like protein, uses a partial paired domain and a homeodomain for DNA recognition. Proc. Natl. Acad. Sci. U.S.A. 95, 1372013725.
  • Keller, C., Arenkiel, B.R., Coffin, C.M., El-Bardeesy, N., Depinho, R.A., and Capecchi, M.R. (2004). Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 18, 26142626.
  • Kikuchi, K., Tsuchiya, K., Otabe, O. et al. (2008). Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 365, 568574.
  • Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., and Wegner, M. (1998). Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237250.
  • Kwang, S.J., Brugger, S.M., Lazik, A. et al. (2002). Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest. Development 129, 527538.
  • Lagha, M., Kormish, J.D., Rocancourt, D., Manceau, M., Epstein, J.A., Zaret, K.S., Relaix, F., and Buckingham, M.E. (2008). Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program. Genes Dev. 22, 18281837.
  • Lagutina, I., Conway, S.J., Sublett, J., and Grosveld, G.C. (2002). Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22, 72047216.
  • Lang, D., and Epstein, J.A. (2003). Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum. Mol. Genet. 12, 937945.
  • Lang, D., Chen, F., Milewski, R., Li, J., Lu, M.M., and Epstein, J.A. (2000). Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J. Clin. Invest. 106, 963971.
  • Lang, D., Lu, M.M., Huang, L., Engleka, K.A., Zhang, M., Chu, E.Y., Lipner, S., Skoultchi, A., Millar, S.E., and Epstein, J.A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884887.
  • Lang, D., Powell, S.K., Plummer, R.S., Young, K.P., and Ruggeri, B.A. (2007). PAX genes: roles in development, pathophysiology, and cancer. Biochem. Pharmacol. 73, 114.
  • Le Douarin, N.M., and Dupin, E. (2003). Multipotentiality of the neural crest. Curr. Opin. Genet. Dev. 13, 529536.
  • Lehembre, F., Muller, S., Pandolfi, P.P., and Dejean, A. (2001). Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene 20, 19.
  • Li, H.G., Wang, Q., Li, H.M., Kumar, S., Parker, C., Slevin, M., and Kumar, P. (2007). PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN. Cancer Lett. 253, 215223.
  • Ludolph, D.C., and Konieczny, S.F. (1995). Transcription factor families: muscling in on the myogenic program. FASEB J. 9, 15951604.
  • Ludwig, A., Rehberg, S., and Wegner, M. (2004). Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556, 236244.
  • Magnaghi, P., Roberts, C., Lorain, S., Lipinski, M., and Scambler, P.J. (1998). HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3. Nat. Genet. 20, 7477.
  • Mansouri, A., Stoykova, A., and Gruss, P. (1994). Pax genes in development. J. Cell Sci. Suppl. 18, 3542.
  • Mansouri, A., Hallonet, M., and Gruss, P. (1996). Pax genes and their roles in cell differentiation and development. Curr. Opin. Cell Biol. 8, 851857.
  • Margue, C.M., Bernasconi, M., Barr, F.G., and Schafer, B.W. (2000). Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene 19, 29212929.
  • Mayanil, C.S., Pool, A., Nakazaki, H., Reddy, A.C., Mania-Farnell, B., Yun, B., George, D., Mclone, D.G., and Bremer, E.G. (2006). Regulation of murine TGFbeta2 by Pax3 during early embryonic development. J. Biol. Chem. 281, 2454424552.
  • Mclean, T.W., and Castellino, S.M. (2008). Pediatric genitourinary tumors. Curr. Opin. Oncol. 20, 315320.
  • Miccadei, S., Provenzano, C., Mojzisek, M., Natali, P.G., and Civitareale, D. (2005). Retinoblastoma protein acts as Pax 8 transcriptional coactivator. Oncogene 24, 69937001.
  • Miller, P.J., Dietz, K.N., and Hollenbach, A.D. (2008). Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts. Protein Sci. [Epub ahead of print].
  • Moase, C.E., and Trasler, D.G. (1989). Spinal ganglia reduction in the splotch-delayed mouse neural tube defect mutant. Teratology 40, 6775.
  • Moase, C.E., and Trasler, D.G. (1990). Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants. Teratology 42, 171182.
  • Morell, R., Friedman, T.B., Moeljopawiro, S., Hartono, Soewito, and Asher, J.H. Jr (1992). A frameshift mutation in the HuP2 paired domain of the probable human homolog of murine Pax-3 is responsible for Waardenburg syndrome type 1 in an Indonesian family. Hum. Mol. Genet. 1, 243247.
  • Morozov, V.M., Massoll, N.A., Vladimirova, O.V., Maul, G.G., and Ishov, A.M. (2008). Regulation of c-met expression by transcription repressor Daxx. Oncogene 27, 21772186.
  • Morris, R.J., Liu, Y., Marles, L., Yang, Z., Trempus, C., Li, S., Lin, J.S., Sawicki, J.A., and Cotsarelis, G. (2004). Capturing and profiling adult hair follicle stem cells. Nat. Biotechnol. 22, 411417.
  • Murakami, M., Tominaga, J., Makita, R., Uchijima, Y., Kurihara, Y., Nakagawa, O., Asano, T., and Kurihara, H. (2006). Transcriptional activity of Pax3 is co-activated by TAZ. Biochem. Biophys. Res. Commun. 339, 533539.
  • Muratovska, A., Zhou, C., He, S., Goodyer, P., and Eccles, M.R. (2003). Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22, 79897997.
  • Nakazaki, H., Reddy, A.C., Mania-Farnell, B.L., Shen, Y.W., Ichi, S., Mccabe, C., George, D., Mclone, D.G., Tomita, T., and Mayanil, C.S. (2008). Key basic helix-loop-helix transcription factor genes Hes1 and Ngn2 are regulated by Pax3 during mouse embryonic development. Dev. Biol. 316, 510523.
  • Nishikawa, S., and Osawa, M. (2007). Generating quiescent stem cells. Pigment Cell Res. 20, 263270.
  • Nishimura, E.K., Jordan, S.A., Oshima, H., Yoshida, H., Osawa, M., Moriyama, M., Jackson, I.J., Barrandon, Y., Miyachi, Y., and Nishikawa, S. (2002). Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416, 854860.
  • Osawa, M., Egawa, G., Mak, S.S., Moriyama, M., Freter, R., Yonetani, S., Beermann, F., and Nishikawa, S. (2005). Molecular characterization of melanocyte stem cells in their niche. Development 132, 55895599.
  • Oshima, H., Rochat, A., Kedzia, C., Kobayashi, K., and Barrandon, Y. (2001). Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 104, 233245.
  • Pani, L., Horal, M., and Loeken, M.R. (2002). Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis. Genes Dev. 16, 676680.
  • Parker, C.J., Shawcross, S.G., Li, H. et al. (2004). Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin. Int. J. Cancer 108, 314320.
  • Passeron, T., Valencia, J.C., Bertolotto, C., Hoashi, T., Le Pape, E., Takahashi, K., Ballotti, R., and Hearing, V.J. (2007). SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc. Natl. Acad. Sci. U.S.A. 104, 1398413989.
  • Phelan, S.A., Ito, M., and Loeken, M.R. (1997). Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 46, 11891197.
  • Pingault, V., Bondurand, N., Kuhlbrodt, K. et al. (1998). SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18, 171173.
  • Ploski, J.E., Shamsher, M.K., and Radu, A. (2004). Paired-type homeodomain transcription factors are imported into the nucleus by karyopherin 13. Mol. Cell. Biol. 24, 48244834.
  • Plummer, R.S., Shea, C.R., Nelson, M., Powell, S.K., Freeman, D.M., Dan, C.P., and Lang, D. (2008). PAX3 expression in primary melanomas and nevi. Mod. Pathol. 21, 525530.
  • Potterf, S.B., Furumura, M., Dunn, K.J., Arnheiter, H., and Pavan, W.J. (2000). Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 107, 16.
  • Potterf, S.B., Mollaaghababa, R., Hou, L., Southard-Smith, E.M., Hornyak, T.J., Arnheiter, H., and Pavan, W.J. (2001). Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev. Biol. 237, 245257.
  • Puppo, F., Griseri, P., Fanelli, M., Schena, F., Romeo, G., Pelicci, P., Ceccherini, I., Ravazzolo, R., and Patrone, G. (2002). Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression. FEBS Lett. 523, 123127.
  • Read, A.P., and Newton, V.E. (1997). Waardenburg syndrome. J. Med. Genet. 34, 656665.
  • Roeb, W., Boyer, A., Cavenee, W.K., and Arden, K.C. (2007). PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Proc. Natl. Acad. Sci. U.S.A. 104, 1808518090.
  • Russell, W.L., and Roscoe, B. (1947). Splotch, a new mutation in the house mouse, Mus musculus. Genetics 32, 107.
  • Ryu, B., Kim, D.S., Deluca, A.M., and Alani, R.M. (2007). Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE 2, e594.
  • Sanford, L.P., Ormsby, I., Gittenberger-De Groot, A.C., Sariola, H., Friedman, R., Boivin, G.P., Cardell, E.L., and Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124, 26592670.
  • Scheidler, S., Fredericks, W.J., Rauscher, F.J. III, Barr, F.G., and Vogt, P.K. (1996). The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. U.S.A. 93, 98059809.
  • Schepsky, A., Bruser, K., Gunnarsson, G.J., Goodall, J., Hallsson, J.H., Goding, C.R., Steingrimsson, E., and Hecht, A. (2006). The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol. Cell. Biol. 26, 89148927.
  • Scholl, F.A., Kamarashev, J., Murmann, O.V., Geertsen, R., Dummer, R., and Schafer, B.W. (2001). PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res. 61, 823826.
  • Shapiro, D.N., Sublett, J.E., Li, B., Downing, J.R., and Naeve, C.W. (1993). Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 51085112.
  • Short, S., and Holland, L.Z. (2008). The evolution of alternative splicing in the pax family: the view from the Basal chordate amphioxus. J. Mol. Evol. 66, 605620.
  • Sieber-Blum, M., Grim, M., Hu, Y.F., and Szeder, V. (2004). Pluripotent neural crest stem cells in the adult hair follicle. Dev. Dyn. 231, 258269.
  • Smit, D.J., Smith, A.G., Parsons, P.G., Muscat, G.E., and Sturm, R.A. (2000). Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 267, 64136422.
  • Snell, G.D., Dickie, M.M., Smith, P., and Kelton, D.E. (1954). Linkage of loop-tail, leaden, splotch and fuzzy in the mouse. Heredity 8, 271273.
  • Soma, T., and Hibinot, T.Y. (2002). Involvement of Transforming Growth Factor-2 in Catagen Induction During the Human Hair Cycle. J. Invest. Dermatol. 118, 993997.
  • Southard-Smith, E.M., Kos, L., and Pavan, W.J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18, 6064.
  • Stamataki, D., Kastrinaki, M., Mankoo, B.S., Pachnis, V., and Karagogeos, D. (2001). Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors. FEBS Lett. 499, 274278.
  • Stoller, J.Z., Degenhardt, K.R., Huang, L., Zhou, D.D., Lu, M.M., and Epstein, J.A. (2008). Cre reporter mouse expressing a nuclear localized fusion of GFP and beta-galactosidase reveals new derivatives of Pax3-expressing precursors. Genesis 46, 200204.
  • Sturm, R.A., O’sullivan, B.J., Thomson, J.A., Jamshidi, N., Pedley, J., and Parsons, P.G. (1994). Expression studies of pigmentation and POU-domain genes in human melanoma cells. Pigment Cell Res. 7, 235240.
  • Tajbakhsh, S., Rocancourt, D., Cossu, G., and Buckingham, M. (1997). Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127138.
  • Takeda, K., Yasumoto, K., Takada, R., Takada, S., Watanabe, K., Udono, T., Saito, H., Takahashi, K., and Shibahara, S. (2000). Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J. Biol. Chem. 275, 1401314016.
  • Tassabehji, M., Read, A.P., Newton, V.E., Harris, R., Balling, R., Gruss, P., and Strachan, T. (1992). Waardenburg’s syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635636.
  • Tassabehji, M., Read, A.P., Newton, V.E., Patton, M., Gruss, P., Harris, R., and Strachan, T. (1993). Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat. Genet. 3, 2630.
  • Tassabehji, M., Newton, V.E., Liu, X.Z. et al. (1995). The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet. 4, 21312137.
  • Tekin, M., Bodurtha, J.N., Nance, W.E., and Pandya, A. (2001). Waardenburg syndrome type 3 (Klein-Waardenburg syndrome) segregating with a heterozygous deletion in the paired box domain of PAX3: a simple variant or a true syndrome? Clin. Genet. 60, 301304.
  • Terzic, J., and Saraga-Babic, M. (1999). Expression pattern of PAX3 and PAX6 genes during human embryogenesis. Int. J. Dev. Biol. 43, 501508.
  • Thomson, J.A., Murphy, K., Baker, E., Sutherland, G.R., Parsons, P.G., Sturm, R.A., and Thomson, F. (1995). The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 11, 691700.
  • Toma, J.G., Akhavan, M., Fernandes, K.J., Barnabe-Heider, F., Sadikot, A., Kaplan, D.R., and Miller, F.D. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3, 778784.
  • Toma, J.G., Mckenzie, I.A., Bagli, D., and Miller, F.D. (2005). Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23, 727737.
  • Treisman, J., Harris, E., and Desplan, C. (1991). The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev. 5, 594604.
  • Tremblay, P., Kessel, M., and Gruss, P. (1995). A transgenic neuroanatomical marker identifies cranial neural crest deficiencies associated with the Pax3 mutant Splotch. Dev. Biol. 171, 317329.
  • Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., and Fuchs, E. (2004). Defining the epithelial stem cell niche in skin. Science 303, 359363.
  • Vogan, K.J., Epstein, D.J., Trasler, D.G., and Gros, P. (1993). The splotch-delayed (Spd) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 17, 364369.
  • Waardenburg, P.J. (1951). A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am. J. Hum. Genet. 3, 195253.
  • Wang, Q., Fang, W.H., Krupinski, J., Kumar, S., Slevin, M., and Kumar, P. (2008). Pax genes in embryogenesis and oncogenesis. J. Cell. Mol. Med. [Epub ahead of print].
  • Watanabe, A., Takeda, K., Ploplis, B., and Tachibana, M. (1998). Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat. Genet. 18, 283286.
  • Wellbrock, C., Rana, S., Paterson, H., Pickersgill, H., Brummelkamp, T., and Marais, R. (2008). Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE 3, e2734.
  • Wiggan, O., Taniguchi-Sidle, A., and Hamel, P.A. (1998). Interaction of the pRB-family proteins with factors containing paired-like homeodomains. Oncogene 16, 227236.
  • Wilson, D.S., Guenther, B., Desplan, C., and Kuriyan, J. (1995). High resolution crystal structure of a paired (Pax) class cooperative homeodomain dimer on DNA. Cell 82, 709719.
  • Wollnik, B., Tukel, T., Uyguner, O., Ghanbari, A., Kayserili, H., Emiroglu, M., and Yuksel-Apak, M. (2003). Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome. Am. J. Med. Genet. A 122A, 4245.
  • Woloshin, P., Song, K., Degnin, C., Killary, A.M., Goldhamer, D.J., Sassoon, D., and Thayer, M.J. (1995). MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. Cell 82, 611620.
  • Wu, J., Saint-Jeannet, J.P., and Klein, P. (2003). Wnt–frizzled signaling in neural crest formation. Trends Neurosci. 26, 4045.
  • Wu, M., Li, J., Engleka, K.A., Zhou, B., Lu, M.M., Plotkin, J.B., and Epstein, J.A. (2008). Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice. J. Clin. Invest. 118, 20762087.
  • Xu, W., Rould, M.A., Jun, S., Desplan, C., and Pabo, C.O. (1995). Crystal structure of a paired domain-DNA complex at 2.5 A resolution reveals structural basis for Pax developmental mutations. Cell 80, 639650.
  • Yasumoto, K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K., and Shibahara, S. (2002). Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J. 21, 27032714.
  • Yavuzer, U., and Goding, C.R. (1994). Melanocyte-specific gene expression: role of repression and identification of a melanocyte-specific factor, MSF. Mol. Cell. Biol. 14, 34943503.
  • Yuan, S.S., Yeh, Y.T., and Lee, E.Y. (2002). Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member. Biochem. Biophys. Res. Commun. 296, 10191025.
  • Zhang, R., Poustovoitov, M.V., Ye, X. et al. (2005). Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 1930.
  • Zlotogora, J., Lerer, I., Bar-David, S., Ergaz, Z., and Abeliovich, D. (1995). Homozygosity for Waardenburg syndrome. Am. J. Hum. Genet. 56, 11731178.